Day: April 1, 2023
New York, NY, March 31, 2023 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII” or “The Company”), www.gtii-us.com, announced today that it has signed a third extension agreement with Wildfire Media Corp, (“Wildfire”), extending the original agreement to May 15, 2023, in order to allow Wildfire more time to complete the two-year PCAOB audit undertaken by UHY, LLP, an auditing firm based in Sterling Heights, MI. The two-year audit is a requirement in order to complete and close the acquisition of Wildfire and the 1-800-LAWFIRM brand by GTII.
About GTII: GTII is a publicly traded Company incorporated in the state of Nevada, specializing in the pursuit of acquiring new and innovative technologies. Visit GTII here https://gtii-us.com/
Please follow our Company at: www.otcmarkets.com/stock/GTII
About Wildfire...
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
InterCure 2020-2022 Financials
InterCure 2020-2022 FinancialsRecord fiscal year 2022 revenue of $150 million
Record fiscal year 2022 Adjusted EBITDA* of $32 million
Record fiscal year 2022 net income of $17 million
Generated $20 Million cash flow from operations
Strong balance sheet with over $95 million cash
NEW YORK, TORONTO, and HERZLIYA, Israel, March 31, 2023 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”) is pleased to announce its financial and operating results for the fourth quarter and year ended December 31, 2022. All amounts are expressed in New Israeli Shekels (NIS) or Canadian dollars ($), unless otherwise noted.Full Year 2022 Key Financial & Operating Highlights (Cannabis Sector)Record fiscal year 2022 revenue of $150 million...
Mydecine Reports Financial Results for the Year Ended December 2022
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
DENVER, March 31, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported company highlights and financial results for the years ended December 31, 2022 and 2021.
Company Highlights
In 2022, Mydecine continued to define its focus and clinical trial execution strategy. The Company reached several milestones with the goal to become an efficiently operated biotechnology company. Of significant note, Mydecine announced several advancements in drug development including first and second-generation drug candidates. We have identified and pursued the indications that management believes will be most promising from the view of treating global...
IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update
Written by Customer Service on . Posted in Public Companies.
Revenue increased 14% annually driven by greater adoption of medical treatments.
BRENTWOOD, Tenn., March 31, 2023 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today reported its financial results for the year ended December 31, 2022.
Financial Highlights from FY 2022 (all comparisons are with IMAC for the year ended December 31 unless otherwise indicated):Annual revenue was $16.1 million, up 14.3% from $14.1 million in 2021
Patient revenue increased to $105 per visit compared to $84 per visit in 2021Corporate Highlights in Q4 2022 and Year To Date 2023:Completed the sale of The BackSpace to Curis Functional Health.
Completed the...